Post your CV - It only takes a few seconds

Molecule jobs

Sort by: relevance - date
Page 1 of 15 jobs
  • Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which…
  • Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which can be…
  • A ligand can be an ion, another protein, a nucleic acid, a small molecule, or a water molecule.
  • Each binding site usually binds one or a few specific molecules,…
QTC recruitment
Ghent
Easily apply
  • Their focus lies on the development of small molecule drugs for severe diseases by targeting GPCR\u2019s, a class of membrane proteins with massive druggable…
QTC recruitment
Ghent
Easily apply
  • Their focus lies on the development of small molecule drugs for severe diseases by targeting GPCR\u2019s, a class of membrane proteins with massive druggable…
QTC recruitment
Ghent
Easily apply
  • Their focus lies on the development of small molecule drugs for severe diseases by targeting GPCR\u2019s, a class of membrane proteins with massive druggable…
  • Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which…
Ardena
Ghent
Easily apply
  • We assist pharmaceutical companies, from virtual biotech to big pharma, in bringing their valued molecule(s) to the clinic and market.
Ardena
Ghent
Easily apply
  • We assist pharmaceutical companies, from virtual biotech to big pharma, in bringing their valued molecule(s) to the clinic and market.
  • 32 days holiday a year.
VIB-UGent Center for Inflammation Research
Ghent
  • As a scaffold molecule, RIPK1 facilitates the activation of the MAPK and NF-kB pathways and prevents cell death.
  • Be able to work independently and on a team.
  • Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which…
  • Ablynx engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of…
  • Ablynx, a Sanofi company, is engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments , which…
  • Ablynx, a Sanofi company, is engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments , which…
Ardena
Ghent
Easily apply
  • We assist pharmaceutical companies, from virtual biotech to big pharma, in bringing their valued molecule(s) to the clinic and market.
  • You are a team player.

We have removed 0 job posting very similar to those already shown. To see the additional result, you may repeat your search with the omitted job posting included.

» Post your CV - It only takes a few seconds